Frontiers in Cancer Research

Introduction: Evolution in Cancer (Carlo Maley and Lauren Merlo)

Section I: Neoplastic Progression

1. Epigenetics of clonal evolution in neoplastic progression (Brian Reid)







2. The population genetics of neoplasms (Mary Kuhner, Simon Tavare or Josh Plotkin)







3. Diversity in neoplasms (Lauren Merlo)







4. How do clones expand? (Doug Brash)







5. Evolution of cancer stem cells (Darryl Shibata & Simon Tavare)







6. Competition and parasitism in and around neoplasms (TBD)







7. Cooperation in and around neoplasms (Thea Tlsty or Charis Eng)







8. Evolution of metastasis (James Talmadge, Rene Bernards or Bob Weinberg)








Section II: Interventions


9. Clonal evolution in cancer prevention (Ernie Hawk or Scott Lippman)







10. How to design multidrug therapy (TBD)







11. Drug scheduling and selection for resistance (Natalia Komarova, Franziska Michor or E.A. Gaffney)







12. Cechaxia and other causes of cancer mortality (John Pepper)

Dr. Carlo C. Maley is an associate professor in the Biodesign Institute and the School of Life Sciences at Arizona State University. He is also the director of the Center of Evolution and Cancer at the University of California San Francisco, and the associate director of the Centre of Evolution and Cancer at the Institute of Cancer Research in London, UK. Dr. Maley earned a bachelor's degree in computer science and psychology from Oberlin College. A Marshall Scholarship allowed him to obtain his master's degree in zoology (evolutionary theory) from the University of Oxford, studying with W.D. Hamilton. He completed his education at Massachusetts Institute of Technology, with a doctorate in computer science (computational biology) working with Rodney Brooks and Michael Donohue. He did his postdoctoral training with Stephanie Forrest at the University of New Mexico and Brian J. Reid at the Fred Hutchinson Cancer Research Center. His research focuses on the application of evolutionary biology and ecology to cancer in order to address problems in the prevention, management and treatment of cancer.

Mel Greaves trained in Zoology and Immunology at University College in London and at the Karolinska Institute in Stockholm before focusing his research on cancer and leukaemia while at the Imperial Cancer Research Fund in London. Earlier in his career, he introduced novel, antibody/flow cytometry-based methods for biological classification of leukaemias that led to insights into the cellular origins of disease and more specific allocation of treatment. Greaves is responsible for establishing the first Leukaemia Research Fund Centre at The Institute of Cancer Research, London. His teams' work on the molecular genetics of childhood leukaemia uncovered the pre-natal origin of this disease and shed light on its possible infectious causes. His current research is focussed on stem cells, genetic architecture and clonal evolution in leukaemia and on the